Aligos Therapeutics ALGS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 8.25 | 116 | 43 | 39.03 | 151 | |
| 2024Q4 | 39.84 | -29 | -82 | -103.65 | 70 | |
| 2024Q3 | 8.66 | 50 | -32.83 | -19 | -19.53 | 88 |
| 2024Q2 | 8.75 | 67 | 7.97 | 5 | 4.28 | 109 |
| 2024Q1 | 24.50 | 60 | -45.91 | -35 | -24.95 | 128 |
| 2023Q4 | 16.60 | 92 | -37.97 | -28 | -23.50 | 152 |
| 2023Q3 | 18.68 | 55 | -28.99 | -18 | -18.79 | 86 |
| 2023Q2 | 24.28 | 70 | -24.34 | -19 | -16.49 | 106 |
| 2023Q1 | 21.85 | 85 | -24.34 | -23 | -17.10 | 122 |
| 2022Q4 | 23.82 | 104 | -19.38 | -22 | -14.09 | 147 |
| 2022Q3 | 27.50 | 122 | -14.38 | -19 | -10.75 | 164 |
| 2022Q2 | 30.25 | 137 | -13.75 | -20 | -10.14 | 183 |
| 2022Q1 | 53.75 | 153 | -21.10 | -36 | -15.98 | 210 |
| 2021Q4 | 296.75 | 185 | -18.78 | -38 | -15.13 | 235 |
| 2021Q3 | 387.75 | 217 | -17.17 | -33 | -13.95 | 263 |
| 2021Q2 | 509.63 | 169 | -16.38 | -30 | -13.36 | 212 |
| 2021Q1 | 568.50 | 195 | -13.33 | -28 | -11.07 | 235 |
| 2020Q4 | 691.25 | 220 | -34 | -19.26 | 265 | |
| 2020Q3 | -137 | -33 | -27.65 | 92 | ||
| 2020Q2 | 122 | -21 | 149 |